These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32444693)

  • 21. Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
    Henry RA
    CMAJ; 2020 Jun; 192(26):E728. PubMed ID: 32601254
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19: The heart of the issue.
    Woodward B; Kermali M
    J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802
    [No Abstract]   [Full Text] [Related]  

  • 23. Update Alert 4: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Mackey K; Kansagara D; Vela K
    Ann Intern Med; 2020 Nov; 173(9):W147-W148. PubMed ID: 32956599
    [No Abstract]   [Full Text] [Related]  

  • 24. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
    Dudoignon E; Moreno N; Deniau B; Coutrot M; Longer R; Amiot Q; Mebazaa A; Pirracchio R; Depret F; Legrand M
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):453-455. PubMed ID: 32565254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].
    Valdes-Socin H; Jouret F; Vroonen L; Scheen AJ; Lancellotti P
    Rev Med Liege; 2020 Sup; 75(S1):123-129. PubMed ID: 33211434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
    Bloch MJ
    J Am Coll Cardiol; 2020 Jul; 76(3):277-279. PubMed ID: 32674791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further developments in the literature on RAAS inhibitors and COVID-19.
    Quinn KL; Fralick M; Zipursky JS; Stall NM
    CMAJ; 2020 Jun; 192(26):E727. PubMed ID: 32601253
    [No Abstract]   [Full Text] [Related]  

  • 29. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Haug G; Eapen MS; Sohal SS
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427429
    [No Abstract]   [Full Text] [Related]  

  • 30. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Lubel J; Garg M
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427428
    [No Abstract]   [Full Text] [Related]  

  • 31. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Birnbaum RA
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427430
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
    Bobkova I; Kamyshova E; Rudenko T; Stavrovskaya E; Moiseev S
    Med Hypotheses; 2020 Oct; 143():109888. PubMed ID: 32480248
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury.
    Kow CS; Hasan SS
    J Am Soc Nephrol; 2020 Aug; 31(8):1917-1918. PubMed ID: 32639940
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular disease and the impact of COVID-19.
    Yoganathan A; Sajjad MS; Harky A
    J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
    [No Abstract]   [Full Text] [Related]  

  • 35. What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?
    Elijovich F; Laffer CL
    Hypertension; 2020 Sep; 76(3):665-669. PubMed ID: 32783759
    [No Abstract]   [Full Text] [Related]  

  • 36. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.
    Vaduganathan M; Solomon SD
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427431
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Şen S; Üresin AY
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):631-634. PubMed ID: 33034579
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
    Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
    mBio; 2020 May; 11(3):. PubMed ID: 32444383
    [No Abstract]   [Full Text] [Related]  

  • 39. Renin-angiotensin system inhibition in COVID-19 patients: Friend or foe?
    Karadağ B
    Anatol J Cardiol; 2020 Jul; 24(1):30-31. PubMed ID: 32628135
    [No Abstract]   [Full Text] [Related]  

  • 40. Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS).
    Bigiani A
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2395. PubMed ID: 32435852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.